
News|Articles|June 1, 2002
Vioxx (Rofecoxib tablets and oral suspension) Merck & Co., Inc.
New Indication: COX-2 inhibitor gains rheumatoid arthritis indication
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Amivantamab, chemo combo shows nearly 3-year survival in EGFR exon 20 lung cancer
4
Anne Mall, M.H.A., on automating prior authorization approval requests | PBMI 2026
5
























